Esmolol cardioplegia: The cellular mechanism of diastolic arrest

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 552-560

  Fallouh, Hazem B ^a   Bardswell, Sonya C ^a   McLatchie, Linda M ^a   Shattock, Michael J ^a   Chambers, David J ^a   Kentish, Jonathan C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac myocytes; Cardioplegia; Esmolol; Fast Na channel; L type Ca channel

Indexed keywords

ATENOLOL; CALCIUM ION; ESMOLOL; FURA 2; THAPSIGARGIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; PROPANOLAMINE DERIVATIVE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CARDIOPLEGIA; CONTROLLED STUDY; DIASTOLE; DRUG MECHANISM; FLUORESCENCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE CONDUCTANCE; HEART MUSCLE POTENTIAL; IC 50; INOTROPISM; ISOLATED HEART; MALE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMERE; SARCOPLASMIC RETICULUM; SODIUM CURRENT; VOLTAGE CLAMP; ACTION POTENTIAL; ANIMAL; CALCIUM SIGNALING; DOSE RESPONSE; DRUG EFFECTS; HEART ARREST; HEART CONTRACTION; HEART MUSCLE CELL; HEART PACING; HEART VENTRICLE; HEART VENTRICLE FUNCTION; IN VITRO STUDY; METABOLISM; MUSCLE FIBRIL; PERFUSION; PROCEDURES; TIME; WISTAR RAT;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CARDIAC PACING, ARTIFICIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ARREST, INDUCED; HEART VENTRICLES; IN VITRO TECHNIQUES; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOFIBRILS; PERFUSION; PROPANOLAMINES; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TIME FACTORS; VENTRICULAR FUNCTION;

EID: 77954803502     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq058     Document Type: Article

References (27)

1. Braimbridge MV, Chayen J, Bitensky L, Hearse DJ, Jynge P, Cankovic-Darracott S. Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg 1977;74:900-906.
2. Snabaitis AK, Shattock MJ, Chambers DJ. Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation 1997;96: 3148-3156.
3. 2-cotransport inhibition combined with calcium desensitization. Transplantation 1999;68:1444-1453.
4. Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C. The steady state TTX-sensitive ('window') sodium current in cardiac Purkinje fibres. Pflugers Arch 1979;379:137-142.
5. Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003;75:S661-S666.
6. Corvera JS, Kin H, Dobson GP, Kerendi F, Halkos ME, Katzmark S et al. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg 2005;129: 599-606.
7. Jayawant AM, Stephenson ER Jr, Matte GS, Prophet GA, LaNoue KF, Griffith JW et al. Potassium-channel opener cardioplegia is superior to St. Thomas' solution in the intact animal. Ann Thorac Surg 1999;68:67-74.
8. Roth E, Torok B. Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res Cardiol 1991;86:422-433.
9. Hohnloser SH, Meinertz T, Klingenheben T, Sydow B, Just H. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group. Am J Cardiol 1991;67: 1319-1323.
10. Sweeney MS, Frazier OH. Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg 1992;54:1065-1070.
11. Geissler HJ, Davis KL, Laine GA, Ostrin EJ, Mehlhorn U, Hekmat K et al. Myocardial protection with high-dose beta-blockade in acute myocardial ischaemia. Eur J Cardi-othorac Surg 2000;17:63-70.
12. Mehlhorn U, Sauer H, Kuhn-Regnier F, Sudkamp M, Dhein S, Eberhardt F et al. Myo-cardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg 1999;7:549-557.
13. Scorsin M, Mebazaa A, Al Attar N, Medini B, Callebert J, Raffoul R et al. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardi-oplegia. J Thorac Cardiovasc Surg 2003;125:1022-1029.
14. Bessho R, Chambers DJ. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg 2001;122: 993-1003. (Pubitemid 35462668)
15. Ede M, Ye J, Gregorash L, Summers R, Pargaonkar S, LeHouerou D et al. Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg 1997;63:721-727.
16. Bessho R, Chambers DJ. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischaemia in the rat. J Thorac Cardiovasc Surg 2002; 124:340-351.
17. 2+ sensitivity in ventricular myocytes. Circ Res 2007;100:864-873.
18. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
19. Neumann AK, Yang J, Biju MP, Joseph SK, Johnson RS, Haase VH et al. Hypoxia indu-cible factor 1 alpha regulates T cell receptor signal transduction. Proc Natl Acad Sci USA 2005;102:17071-17076.
20. + current in rat ventricular myocytes. Methods Find Exp Clin Pharmacol 2006;28: 697-702.
21. Honerjager P, Loibl E, Steidl I, Schonsteiner G, Ulm K. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedebergs Arch Pharmacol 1986;332:184-195.
22. Arlock P, Wohlfart B, Sjoberg T, Steen S. The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J 2005;39:250-254.
23. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 1977;69:497-515.
24. Lowenthal DT, Porter RS, Saris SD, Bies CM, Slegowski MB, StaudacherA.Clinical pharmacology, pharmacodynamics and interactions with esmolol. Am J Cardiol 1985;56:14F-18F.
25. Letienne R, Vie B, Le Grand B. Pharmacological characterisation of sodium channels in sinoatrial node pacemaking in the rat heart. Eur J Pharmacol 2006;530:243-249.
26. 2+ clock and membrane ion channel clock underlie robust initiation and regulation of cardiac pacemaker function. Cardiovasc Res 2008;77:274-284.
27. Erhardt PW, Woo CM, Matier WL, Gorczynski RJ, Anderson WG. Ultra-short-acting beta-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)-propanolamines having esters on the aryl function. J Med Chem 1983;26:1109-1112.